Newsletter | August 6, 2026

08.06.26 -- Avoiding Common Pitfalls In CDMO–Sponsor Relationships Through Integrated Execution Models

SPONSOR

Webinar: The Future of Cell Culture Media Development: Predictive Modeling and AI

Discover how predictive modeling and AI are transforming cell culture media development for biologics. Thermo Fisher Scientific experts explore how integrating biological, analytical, and process data can guide formulation optimization, focus experimental efforts, and accelerate development. Learn how computational modeling and scientific expertise work together to support more informed, efficient, and data-driven media development decisions. Click here to learn more.

FOCUS ON OUTSOURCING

Avoiding Common Pitfalls In CDMO–Sponsor Relationships Through Integrated Execution Models

Let's delve into the key pitfalls to avoid when working with a CDMO and the integrated execution model that solves or mitigates these pitfalls before they occur.

Effect Of Shelf Cooling Rate On The Nucleation Temperature Of Ice

Freezing conditions shape ice structure, mass transfer resistance, and drying efficiency. Data shows how cooling rate, vial size, and nucleation interact to optimize freeze-drying.

Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes

See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.

The CDMO Sorting Hat: Selecting The Right CDMO In An Era Of Complexity

Evaluating CDMOs requires looking beyond reactor volume and upfront costs. Success hinges on securing resilient capacity, adopting advanced technologies, and ensuring strategic alignment.

Bispecific T- Cell Engager (BiTE) Screening, Automated Pipeline

View automated, high‑throughput BiTE screening in mammalian cells, enabling rapid discovery of efficacious variants through precise genomic integration and scalable workflows.

How Real-Time Visibility Is Changing Outsourced Gene Therapy Programs

Outsourced gene therapy programs suffer from fragmented visibility across CDMO networks, and a real-time integrated operating model unifies execution and risk data to enable continuous insight.

Shaping The Next Era Of Biologics Manufacturing In North Carolina

North Carolina is a leading U.S. biopharma manufacturing hub, driven by FUJIFILM Biotechnologies’ investment in a scalable, talent-rich, resilient, and integrated network.

Bringing Predictability To Cell Line Development

Targeted integration adds predictability to cell line development by cutting clone screening, improving expression consistency, and accelerating timelines to ease early CMC bottlenecks.

Handling Demanding Active Ingredients Safely And Efficiently

Discover three flexible fill‑finish and syringe assembly systems to boost performance, accuracy, and scalability, enabling efficient processing of diverse formats and supporting rapid CDMO growth.

Redefining CAR-T Speed And Strength: A Conversation

Explore how an autologous CAR-T platform is addressing challenges in cell therapy manufacturing. A three-day process shortens cycles, improves T-cell potency and durability, and reduces costs.

Increasing Batch Size And Reducing Cycle Times For A Biologic

JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.

Inclusion Bodies: Mother Nature's Help Or Hindrance?

Examine strategies to improve the performance of IB processes as well as the pros and cons of soluble and insoluble processes: isolating, solubilizing, and properly refolding.

OUTSOURCING SOLUTIONS

Capabilities Update June 2026: Microbial Development - Novartis Contract Manufacturing

Capabilities Update June 2026: Microbial Manufacturing - 53Biologics

Non-Viral Delivery Of Complex Cargos For Large-Scale CAR-T Manufacturing - Lonza

Early Developability Assessment For Smarter Antibody Selection - Coriolis Pharma

Achieve Efficient Viral Vector Production At Any Phase - AGC Biologics

Leveraging Advanced Tech, Proven Expertise From CLD And Beyond - Catalent

SPONSOR

Webinar: Before IND Know: How to Overcome Early Development Challenges Before They Impact Your Program

Move your biologic candidate toward the clinic with greater confidence. Join Lonza’s Dr. Yvette Stallwood as she shares real-world case studies demonstrating how early developability insights can resolve manufacturability, quality, expression, and immunogenicity challenges. Learn practical strategies to strengthen candidate selection, reduce development risk, improve readiness for IND-enabling activities, and accelerate clinical development success. Click here to learn more.

Connect With Bioprocess Online: